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Smad7 mediates apoptosis induced by transforming growth
factor b in prostatic carcinoma cells
Maréne Landström*, Nils-Erik Heldin†, Shizhong Bu*, Annika Hermansson†,
Susumu Itoh*‡, Peter ten Dijke*‡ and Carl-Henrik Heldin*
Transforming growth factor b (TGF-b ) is an important
regulator of apoptosis in some cell types, but the
underlying molecular mechanisms are largely unknown.
TGF-b signals through type I and type II receptors and
downstream effector proteins, termed Smads. TGF-b
induces the phosphorylation of Smad2 and Smad3
(receptor-activated Smads) which associate with
Smad4 and translocate to the nucleus, where they
regulate gene transcription [1]. Smad7 protein is
induced by TGF-b 1 and has been classified as an
inhibitory Smad. Smad7 prevents phosphorylation of
receptor-activated Smads, thereby inhibiting TGF-b -
induced signaling responses [1]. Smad7 expression is
increased in rat prostatic epithelial cells undergoing
apoptosis as a result of castration [2]. Here we have
shown that TGF-b 1 treatment or ectopic expression of
Smad7 in human prostatic carcinoma cells (PC-3U)
induces apoptosis. Furthermore, TGF-b 1-induced
apoptosis was prevented by inhibition of Smad7
expression, by antisense mRNA in stably transfected
cell lines or upon transient transfection with antisense
oligonucleotides in several investigated cell lines.
These findings provide evidence for a new effector
function for Smad7 in TGF-b 1 signaling.
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Results and discussion
By immunohistochemical analyses of the ventral rat
prostate, we previously observed an increase in the TGF-b
signaling molecules Smad2, Smad3 and Smad4 in associa-
tion with apoptosis induced by castration, together with
increased immunoreactivity for phosphorylated and acti-
vated Smad2 [2]. In parallel, there was an increase in the
immunoreactivity for Smad7, which was present in epithe-
lial cells showing characteristic signs of apoptotic nuclei, in
the form of condensed and fragmented nuclei [2,3]. The
finding that Smad7 is expressed in prostatic epithelial cells
undergoing apoptosis [2] led us to investigate whether
Smad7 is important in the regulation of TGF-b 1-induced
apoptosis in PC-3U cells. Consistent with previous obser-
vations in mink lung cells, human thyroid carcinoma cells
and glioma cells [1], we observed a rapid increase in Smad7
mRNA expression after TGF-b 1 stimulation of PC-3U
cells, reaching a peak level after 1.5 hours (Figure 1a). We
also observed an increased level of Smad7 protein after
6–24 hours of TGF-b 1 challenge (Figure 1b). The protein
levels of Smad7 remained high 48 hours after TGF-b 1
stimulation, but decreased after 72 hours (data not shown).
Stimulation of PC-3U cells by 10 ng/ml TGF-b 1 in
medium containing 1% fetal bovine serum (FBS) for
24 hours, 48 hours and 72 hours led to an increased number
of apoptotic cells compared with unstimulated control
cells, as shown by a DNA-fragmentation assay (Figure 1c).
Thus, TGF-b 1 induces Smad7 expression, which precedes
the induction of apoptosis in PC-3U cells.
To investigate the effects of Smad7, FLAG-tagged Smad7
(F–Smad7) was stably transfected into PC-3U cells under
the control of an inducible metallothionein promoter
(pMEP4). Several different subclones were isolated; two of
the clones (clones C and I; see Supplementary material)
showed high expression of F–Smad7 measured after
12 hours of treatment with CdCl2 (optimum concentration
0.5–1.0 m M; data not shown). A low amount of F–Smad7
was seen also in the absence of CdCl2, owing to the leaki-
ness of the metallothionein promoter. The expression of
F–Smad7 was not affected by TGF-b 1 stimulation (see
Supplementary material). No induction of Smad7 mRNA
was seen in untransfected control cells after stimulation
with CdCl2 at the different time points investigated.
Ectopic expression of F–Smad7 inhibited TGF-b -mediated
upregulation of plasminogen activator inhibitor 1 (PAI-1)
and growth inhibition (see Supplementary material); there-
fore, the expressed F–Smad7 was functionally active [1,4,5].
To investigate the effects of Smad7 expression on apopto-
sis, several different assays were used. DNA was isolated
from confluent, CdCl2-treated cultures of F–Smad7-
expressing clone I and mock-transfected PC-3U cells and
analyzed by electrophoresis in an agarose gel. As seen in
Figure 2a, TGF-b 1-induced DNA fragmentation was
observed in the mock-transfected control cells. However,
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in the F–Smad7-transfected PC-3U cells (clone I), DNA
fragmentation was also observed in the absence of TGF-b 1
after induction of F–Smad7 expression by CdCl2; this
finding suggests that F–Smad7 overexpression induces
apoptosis (Figure 2a, lane 7). Moreover, TdT-mediated
dUTP nick-end labeling (TUNEL) analyses showed an
increased number of apoptotic cells in F–Smad7-overex-
pressing cells compared with control cells (Figure 2b). A
small increase in the number of TUNEL-positive cells was
also observed in the control cells after CdCl2 stimulation,
but there was a striking increase in the number of
TUNEL-positive cells in the F–Smad7-expressing clones
after such stimulation. Moreover, the amount of early apop-
totic cells, as visualised by ApoAlert mitochondrial mem-
brane sensor kit (Mitosensor; Clontech) was already
increased in response to the leaky expression of Smad7. In
comparison, the control PC-3U cells transfected with
empty vector showed normal uptake of the dye (data not
shown). Thus, Smad7 overexpression induces apoptosis as
shown by several different methods. Treatment with the
caspase inhibitor zVAD-fmk decreased the number of
apoptotic cells in a dose-dependent way (see Supplemen-
tary material), which shows that Smad7-mediated apopto-
sis involves the action of caspases. 
To explore whether Smad7 expression is necessary for
TGF- b 1-induced apoptosis, we attempted to block
Smad7 expression by an antisense approach. The Smad7
cDNA was cloned in the reverse orientation downstream
of a cytomegalovirus promoter and stably transfected
into PC-3U cells. Northern blot analysis revealed high
expression of the antisense Smad7 mRNA (Figure 3a).
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Figure 2
Ectopic expression of Smad7 induces
apoptosis in PC-3U cells. (a) DNA was
extracted from attached cells as well as from
cells floating in the medium of pMEP4
F–Smad7-transfected PC-3U cells (clone I)
and control cells transfected with empty vector.
The cells had in both cases been treated for
24 h with or without 1 m M CdCl2, in the
presence or absence of TGF-b 1 in medium
containing 1% FBS. DNA was electrophoresed
in a 1.8% agarose gel and visualized by UV
light. (b) The presence of apoptotic cells was
identified by TUNEL assay according to the
manufacturer’s manual (Roche).
Figure 1
Treatment with TGF-b 1 induces Smad7 expression and apoptosis in
PC-3U cells. (a) Northern blot analysis of Smad7 mRNA expression in
PC-3U cells at various time points after stimulation with TGF- b 1, as
described previously [5]. (b) Western blot analysis of Smad7 on cell
lysates from PC-3U cells stimulated with TGF-b 1 (10 ng/ml) for the
indicated times. (c) Analysis of DNA fragmentation in confluent PC-3U
cells treated with TGF-b 1 by electrophoresis of DNA in a 1.8% agarose
gel, followed by staining with ethidium bromide, UV illumination, and
photography of the gel [9]. Lane 1, markers (M); lane 2, control cells;
lanes 3–5, cells treated with TGF-b 1 for 24 h, 48 h, or 72 h.
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Western blot analysis showed that the TGF- b -induced
increase in Smad7 protein was attenuated in cells trans-
fected with antisense Smad7 (AS-S7) compared with
control cells (Figure 3b). Importantly, AS-S7 cells stimu-
lated with TGF- b 1 for 24–48 hours showed lower
numbers of apoptotic cells than control cells, as analyzed
by DNA fragmentation (Figure 3c), TUNEL or Mitosen-
sor analysis (data not shown). Endogenous Smad7 was pre-
dominantly localized in the nucleus of the PC-3U cells
(control and AS-S7 cells), as analyzed by immunofluores-
cence. After TGF-b 1 stimulation, a fraction of Smad7 was
also close to the cell membrane, as reported previously [5].
There were, therefore, no obvious differences in the sub-
cellular localisation of endogenous Smad7 between AS-S7
PC-3U cells and control cells, except that the intensity of
immunofluorescence was lower (data not shown).
We next transfected synthetic sense and antisense Smad7
phosphorothioate-modified oligonucleotides into PC-3U
cells to confirm that Smad7 can act as a mediator of
TGF-b 1-induced apoptosis. Treatment with TGF-b 1 for
24–48 hours induced apoptosis in control cells transfected
with sense Smad7 oligonucleotides and untreated PC-3U
cells (data not shown), whereas antisense Smad7 oligonu-
cleotides prevented apoptosis, as shown by Mitosensor
analysis (Figure 3d). Similar results were obtained with
the human prostatic carcinoma cell line DU 145 and the
human keratinocyte cell line HaCaT, as shown by 4¢ -6
diamidino-2-phenylindoledihydrochloride (DAPI) stain-
ing, which allows identification and quantification of
apoptotic nuclei (Table 1 and Supplementary material)
and by Mitosensor analysis (data not shown).
In this study we provide evidence that TGF-b 1-induced
apoptosis in human prostatic carcinoma cells is mediated by
Smad7; overexpression of Smad7 potently induces apopto-
sis, and expression of antisense Smad7 mRNA or antisense
oligonucleotides for Smad7 prevents TGF-b 1-induced
apoptosis. Further studies are needed to investigate the
mechanisms by which Smad7 overexpression results in
apoptosis. By contrast, in hematopoietic cells, Smad7
inhibits TGF-b -induced apoptosis [6,7]; there could, there-
fore, be cell-type differences in the proapoptotic effect of
Smad7. Expression of Smad7 is regulated by several differ-
ent stimuli, including the TGF-b family members TGF-b ,
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Figure 3
Antisense Smad7 prevents TGF-b 1-induced apoptosis. (a) Northern
blot analysis of Smad7 mRNA in control cells and in the stably
transfected antisense Smad7 clone (AS-S7). Ectopically expressed
antisense Smad7 (AS-Smad7) is indicated. The blot was reprobed for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a loading
control. (b) Western blot analysis using an anti-Smad7 antiserum of
cell lysates prepared from control PC-3U cells and AS-S7 cells,
stimulated with 10 ng/ml TGF-b 1 for 12 h. (c) Analysis of
fragmentation of DNA isolated from control PC-3U cells and AS-S7
cells, treated or not with TGF-b 1 (10 ng/ml) for 24 h and 48 h, by
electrophoresis in a 1.8% agarose gel, staining with ethidium bromide
and illumination with UV light. (d) Analysis of apoptosis of PC-3U cells
treated with or without TGF-b 1 and/or synthetic antisense Smad7
oligonucleotides for 36 h, by immunofluorescence with Mitosensor
(Clontech). The cationic dye is taken up in normal mitochondria
(yellow-red), whereas in early apoptotic cells this uptake does not
occur (green) [10]. Phosphorothioate single-stranded oligonucleotides
matching region 107–128 (5¢ -GCTGCGGGGAGAAGGGGCGAC-
3¢ ) of the human Smad7 complementary DNA sequence (GenBank
accession number AF010193) were synthesized in the sense and
antisense orientations and used as described by Ulloa et al. [8].
Table 1
Effect of Smad7 antisense oligonucleotides on TGF-b 1 induced
apoptosis.
Apoptotic cells (%)
Cell line Control + TGF-b 1 + TGF-b 1 + TGF-b 1
+ sense Smad7 + antisense Smad7
DU 145 0.8 6.2 5.8 2.4
HaCaT 2.4 11.7 10.5 3.2
Induction of apoptosis in DU 145 cells and HaCaT cells treated with
10 ng/ml TGF-b 1 for 48 h in 1% FBS, which were transfected or not
with phosphorothioate single-stranded oligonucleotides sense and
antisense for Smad7. Nuclei were stained with DAPI and 1,000 cells
were counted in each group.
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activin and bone-morphogenetic protein, as well as epider-
mal growth factor and interferon-g [ 1,8], which suggests that
Smad7 is one of the modulatory mechanisms controlling
TGF-b -induced signaling. Ectopically expressed Smad7 is
found in the nucleus ([5] and data not shown), and the
MH2 domain of Smad7 is similar to the MH2 domain of
receptor-activated Smads and Smad4, which recruit tran-
scriptional (co-)activators and repressors [1]. These findings
suggest that Smad7 may induce proapoptotic factors or
repress antiapoptotic factors. A fraction of the Smad7
protein pool is rapidly exported from the nucleus to the
cytoplasm on stimulation with TGF-b 1 ([5] and data not
shown). The subcellular localization of Smad7 that is
needed to initiate apoptosis is currently under investigation.
Materials and methods
Cell culture 
The human prostatic carcinoma cell lines PC-3U, a subline originating
from PC-3 cells [4], and DU 145 were routinely grown in RPMI 1640
with 10% FBS. HaCaT cells were grown in DMEM with 10% FBS. In
all assays, TGF-b 1 treatment was applied at 10 ng/ml in medium con-
taining 1% FBS.
Stable transfections, metabolic labeling, thymidine
incorporation assay and immunoprecipitation
Stable transfection of PC-3U cells with pMEP4-Smad7 expression
vector or pRKV5 Smad7 antisense expression vector, metabolic labeling
of cells, immunoprecipitation and thymidine incorporation assay were
performed as described previously [5]. Antisense-Smad7-expressing
clones were selected with 0.2 mg/ml gentamicin (GibcoBRL, Life Tech-
nologies). Cells transfected with pMEP4-Smad7 were stimulated with
0.5 m M or 1.0 m M CdCl2 for 12–24 h to induce expression of F–Smad7.
Western blot analysis
For detection of endogenous Smad7, KAF antisera were used [2];
lysates from COS-7 cells transiently transfected with F–Smad7, were
used as a positive control in immunoblotting. The immunoreactivity was
blocked by the peptide used for immunization, demonstrating speci-
ficity (data not shown).
Supplementary material
Figures showing characterization of the stably transfected F–Smad7
clones, thymidine incorporation assay, the caspase dependency of
F–Smad7-induced apoptosis and the importance of Smad7 in TGF-b 1-
induced apoptosis in DU 145 and HaCaT cells are available at
http://current-biology.com/supmat/supmatin.htm.
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